Table 4
Incidence of the most common adverse events
| Placebo (n=308) | Montelukast 10 mg (n=317) | ||||
|---|---|---|---|---|---|
| Adverse event | n | % | n | % | p value* |
| *p value for montelukast v placebo. | |||||
| Influenza | 34 | 11.04 | 38 | 11.99 | 0.71 |
| Headache | 29 | 9.42 | 34 | 10.73 | 0.59 |
| Upper respiratory infection | 21 | 6.82 | 17 | 5.36 | 0.45 |
| Worsening asthma | 15 | 4.87 | 22 | 6.94 | 0.27 |
| Epigastric pain/pyrosis | 6 | 1.95 | 8 | 2.52 | 0.63 |
| Urinary tract infection | 7 | 2.27 | 6 | 1.89 | 0.74 |
| Rhinitis | 6 | 1.95 | 5 | 1.58 | 0.72 |
| Pharyngitis | 4 | 1.30 | 5 | 1.58 | 0.77 |
| Bronchitis | 3 | 0.97 | 5 | 1.58 | 0.24 |
| Total | 125 | 40.58 | 140 | 44.16 | 0.37 |
